Healthtech Startups

Verisma provides technology-enabled solutions for healthcare providers and health plans to manage health information exchange, retrieval, and governance. The company serves healthcare organizations seeking to streamline administrative workflows and retire legacy systems while maintaining accuracy and regulatory compliance.

1 investor

Veri provides personalized metabolic health monitoring and insights to help individuals understand their body's unique responses to food and lifestyle choices. The company serves consumers interested in optimizing their metabolic health through science-backed data and technology.

1 investor

Verisys provides data verification and compliance solutions for healthcare organizations, helping them prevent fraud, manage provider credentialing, and maintain regulatory compliance. The company serves providers, payers, and healthcare networks with real-time monitoring and data accuracy services.

1 investor

Veriteus builds an AI platform that detects deception in human communication by analyzing speech, text, and behavior using machine learning and behavioral science. The platform serves organizations seeking to verify credibility and protect against fraudulent or dishonest communication.

1 investor

Vero BioScience develops a blood-based proteomic test that measures organ-specific protein signatures to assess the biological age of individual organs and detect early signs of age-related disease. The company targets individuals seeking predictive health insights and preventive medicine interventions based on technology developed at Stanford.

1 investor

Verrica Pharmaceuticals is a therapeutics company developing and commercializing treatments for dermatological diseases, including molluscum contagiosum, common warts, and skin cancers such as basal cell and squamous cell carcinoma. Its products serve dermatology prescribers, payers, and patients, with a lead drug-device combination based on topical cantharidin.

1 investor

Versant Health manages vision care benefits and provider relationships for health plan members and employers. The company operates medical and optometric advisory councils to guide policy and quality outcomes in eye care.

1 investor

Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients. The company uses a patient-based discovery engine to identify novel targets for immunotherapy, focusing on treating solid tumors where macrophages are prevalent.

1 investor

Versono Medical develops endovascular medical device technology for interventional cardiology and vascular surgery applications. The company is based in Ireland and the USA with backing from experienced medical device executives and clinicians.

1 investor

Vertigenius develops software for vestibular rehabilitation, combining a clinician portal, patient app, and wearable head sensor to deliver and remotely monitor treatment for patients with vertigo, dizziness, and imbalance. It is aimed at healthcare practitioners, enabling remote assessment, personalised exercise programmes, and progress tracking.

1 investor

Verve Medical is developing the Verve RPD System, an investigational device for renal pelvic denervation—a minimally invasive catheter-based procedure that uses radiofrequency energy to disrupt overactive kidney nerves to lower blood pressure. It targets patients with uncontrolled hypertension who do not respond well to medication.

1 investor

Veryan Medical develops the BioMimics 3D Vascular Stent System, a three-dimensional nitinol stent designed around swirling blood flow mechanics to treat vascular disease. Spun out from Imperial College London, the company serves physicians treating peripheral vascular conditions.

1 investor

Vesalio develops stroke treatment technology, specifically devices and systems for endovascular neurosurgical interventions to treat acute ischemic and hemorrhagic stroke. The company serves hospitals and neurosurgeons seeking advanced treatment options.

1 investor

Vesper is a venture builder in biotechnology that spins out companies in human health and agriculture from early-stage research. The company combines capital deployment, IP structuring, and operational support to commercialize scientific innovations.

1 investor

VetGENUS operates a data platform that harmonizes veterinary clinical records into a shared data lake, offering tools for research, clinical trial recruitment, targeted marketing, and operational analytics. It serves veterinary colleges, manufacturers and CROs, and veterinary clinics, positioning itself as data infrastructure for comparative medicine research.

1 investor

Vetbiolix develops first-in-class therapeutic drugs for companion animals, specifically targeting osteoarthritis, periodontitis, and gut motility disorders in dogs and cats. The company adapts promising drug candidates from human clinical development stages to the veterinary market.

1 investor

Vetcelerator is a veterinary marketing agency that combines digital marketing services with membership benefits for pet brands and veterinary clinics. The company helps veterinary practices grow appointments, reduce operational costs, and improve client experience through data-driven marketing and operational tools.

1 investor

Vetcor is a network of veterinary practices that supports over 900 clinics across the US and Canada through a community-focused collaborative model. The company provides operational support and resources to independent veterinary practices while maintaining their local autonomy and commitment to animal care.

1 investor

A network of veterinary clinics and animal hospitals operating across multiple states in the eastern United States, providing care for pets through their affiliated practices.

1 investor

Vetic operates a network of pet clinics across India, providing veterinary healthcare services including vaccinations, health checks, surgery, deworming, and grooming for pets. It also runs community programs such as vaccination drives at shelters and free health camps in residential societies for pet parents.

1 investor

VetNotes is an AI-powered clinical assistant platform that automates documentation for veterinarians to free up time for patient care. The product targets veterinary professionals globally.

1 investor

Vets Central is an Australian veterinary group that acquires and operates multiple veterinary clinics, maintaining their independence while providing centralized support services. The company serves veterinary teams and pet owners through its network of practices across Australia.

1 investor

Vetspire offers a real-time scheduling and workflow management tool designed for veterinary clinics. The platform enables drag-and-drop appointment scheduling, custom templates, and room assignment to streamline daily operations in veterinary practices.

1 investor

VETSTEM develops regenerative cell therapies based on multipotent mesenchymal stem cells (MSCs) and high-bioavailability pharmaceutical products for treating diseases in pets. The company operates in veterinary biotech, applying molecular-cell technologies and pharmaceutical chemistry to animal health.

1 investor